De Novo Mutations in SLC1A2 and CACNA1A Are Important Causes of Epileptic Encephalopathies
Candace T Myers, Jacinta M McMahon, Amy L Schneider, Slave Petrovski, Andrew S Allen, Gemma L Carvill, Matthew Zemel, Julia E Say-Kally, Amy J LaCroix, Erin L Heinzen, Georgina Hollingsworth, Marina Nikanorova, Mark Corbett, Jozef Gecz, David Coman, Jeremy Freeman, Sophie Calvert, Deepak Gill, Patrick Carney, Tally Lerman-Sagie Show all
The American Journal of Human Genetics | CELL PRESS | Published : 2016
Awarded by NIH National Institute of Neurological Disorders and Stroke Center without Walls
Funding for this study comes from the NIH National Institute of Neurological Disorders and Stroke Center without Walls (U01NS077274, U01NS077276, U01NS077303, U01NS077364, and U01NS077275 to the Epi4K administrative core and 2R01NS069605 to H.C.M.). David Goldstein, Steve Petrou, and Slave Petrovski have interests in companies related to epilepsy precision medicine.